Simone Mori is an Executive Director and Program Leader currently advancing messenger RNA therapies in rare diseases and autoimmunity. They served as Sr. Director of Clinical Development for Rare and Autoimmune Diseases at Moderna from 2022 to 2023, and have held multiple leadership roles at the company since 2019. Prior to that, Simone worked as Associate Director of Early Clinical Development at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2017 to 2019 and was a Postdoctoral Research Associate at Scripps Research from 2013 to 2017. Simone earned their Doctor of Medicine with Honors and a degree in Internal Medicine, Immunology, and Rheumatology from Università Politecnica delle Marche, where they studied from 2003 to 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices